source
- Iowa audit finds PBM kept over $100 million by inflating Medicaid drug costsA recent audit of Iowa's Medicaid program uncovered that a major pharmacy benefit manager used complex claim handling methods that led to higher costs for the state. The review of records from 201…
- Kolon’s cell-based gene therapy misses key endpoints in phase 3 osteoarthritis trialKolon TissueGene reported that its phase 3 study of TG‑C, a cell‑based gene therapy for knee osteoarthritis, failed to meet its co‑primary endpoints. Patients receiving the therapy showed no statis…